@nevets
From my reading of the atrial appendage closure device studies I think they have a limited role for very few patients. They leak a lot, people still get clots, the studies exclude procedural bleeding and the doac arm includes bleeding that may not be a clinical disaster. I’m a fan of John Mandrola at medscape.org. His writing and podcasts are said to be for healthcare professionals only since he assumes his audience understands a lot of technical stuff. He rips apart the stats and methods on a lot of studies and ticks off a lot of people. He talks about your situation in his most recent podcast. He is very critical of the watchman trials, I think he has a point.